Abstract
Background:
Non-invasive brain stimulation (NIBS) has emerged as a potential adjunct to cognitive training for enhancing cognitive performance in older peoples with mild cognitive impairment (MCI). This systematic review and meta-analysis aimed to evaluate the efficacy of combined NIBS and cognitive training on cognitive function in this population.
Methods:
A comprehensive literature search was conducted in PubMed, EBSCOhost, CINAHL Complete, Cochrane Library, ProQuest, Scopus, and Web of Science up to May 2025. The review followed PRISMA guidelines, and methodological quality was assessed using the Oxford Centre for Evidence-Based Medicine levels, the Cochrane Risk of Bias 2 tool (RoB 2) tool for risk of bias, and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach for the certainty of evidence. The protocol was registered in PROSPERO (CRD42024563219). Studies were included if they assessed the effects of NIBS in combination with cognitive training on cognitive outcomes in older peoples with MCI.
Results:
A total of 1,689 records were screened, and 10 studies met the inclusion criteria. The results indicated a moderate positive effect of the combined intervention on attention and processing speed as measured by the Trail-Making Test Part A (TMT-A; effect sizeâŻ=âŻ0.54). Improvements were also observed in global cognition as assessed by the Montreal Cognitive Assessment (MoCA), though the results were not statistically significant (pâŻ>âŻ0.05). No significant effects were found for the Trail-Making Test Part B (TMT-B), with effect sizes ranging from 0.05 to 0.52.
Conclusion:
The combination of NIBS and cognitive training appears to yield beneficial effects on specific cognitive domains, particularly attention and processing speed, in older people with MCI. These findings support the potential role of NIBS as an adjunctive intervention to cognitive training for enhancing cognitive function in this population. Further high-quality randomized controlled trials are warranted to confirm these effects.
Systematic review registration:
https://www.crd.york.ac.uk/PROSPERO/view/CRD42024563219, identifier (CRD42024563219).
1 Introduction
The World Health Organization warns that population aging is accelerating worldwide, with the proportion of individuals aged 60âŻyears and older expected to rise from 12% in 2015 to 22% in 2050, and nearly 80% of them living in low- and middle-income countries (1). Aging is closely associated with a higher prevalence of chronic conditions, including cognitive decline, which often precedes dementia (2). Within this spectrum, mild cognitive impairment (MCI) is a clinical condition characterized by measurable deficits in cognitive function that exceed normal age-related changes but do not yet meet the criteria for dementia (3, 4). Recent epidemiological data indicate that MCI affects 15â24% of older adults, with incidence rates increasing to 60 per 1,000 person-years after age 85 (5). Moreover, the global population aged 65âŻyears and older is projected to grow from 771 million in 2022 to 1.6 billion by 2050, underscoring the urgent need for strategies that promote healthy aging and strengthen health systems to meet this demographic challenge (6). A study by Prince et al. (7) indicates that, worldwide, 23% of healthcare expenditure is allocated to the treatment of diseases in people over 60âŻyears of age, and 7% of that expenditure corresponds to neurological and mental disorders, among which MCI is included. Various factors influence aging, such as health, autonomy, cognitive function or capacity, and quality of life (8, 9). Thus, within older people, there is a group that experiences healthy aging and another that is affected by various pathologies (10). Among the conditions associated with aging is MCI, which is defined as a decline in memory or other cognitive functions greater than expected for a personâs age and educational level (11). MCI is characterized by cognitive impairment that does not significantly interfere with basic or instrumental activities of daily living (12).
In recent years, interest in therapeutic interventions for MCI has grown significantly because of the high risk of progression to dementia (13). Individuals with MCI therefore represent an ideal clinical group for testing and developing therapeutic strategies during the early stages of disease progression (14). Ayala San MartĂn (15) identifies several protective factors that enhance cognitive performance and help delay the onset of dementia. Among the most evidence-based interventions for preventing or slowing the progression of MCI is the combination of physical activity and cognitive stimulation, which promotes health and reduces disease risk, particularly in healthy older peoples (16, 17). Current evidence supports their use as key strategies to improve both cognitive and physical function in this population (18).
Recent interventions have provided substantial evidence for the use of technology-based approaches, such as non-invasive brain stimulation (NIBS), which includes electrical, magnetic, and ultrasound-based methods (19). NIBS is widely applied to modulate cortical excitability, producing facilitatory or inhibitory effects on various behaviors and functions (20). Studies indicate that combining NIBS with other interventions enhances cognitive and physical performance in older peoples with MCI (21). In particular, significant improvements have been reported when NIBS is integrated with physical activity programs (22). Additional research also supports the effectiveness of NIBS alone in improving cognitive function (23). Thus, the combined application of NIBS and cognitive stimulation represents a clinically replicable and promising strategy for managing mild cognitive impairment, as it integrates direct modulation of cortical excitability with functional activation of specific neural networks, enhancing memory, attention, and executive functions, while providing a safe and well-tolerated intervention in older peoples (24-26). Therefore, this systematic review with meta-analysis aimed to evaluate and synthesize the scientific evidence on interventions using NIBS combined with cognitive training on cognitive function in older peoples with MCI.
2 Methods
2.1 Protocol and registration
This systematic review and meta-analysis followed the methodologies outlined by the Cochrane Collaboration (27) and adhered to the PRISMA checklist and flowchart guidelines for reporting (28). The review protocol was registered in the PROSPERO database, CRD42024563219.
2.2 Eligibility criteria
This systematic review and meta-analysis included peer-reviewed original studies, specifically randomized controlled trials (RCTs), with no restrictions on language or publication date, up to May 2025. Studies were excluded if they were conference abstracts, books, book chapters, editorials, letters to the editor, protocol records, reviews, case studies, or non-randomized trials. The inclusion criteria were guided by the PICOS framework (Population, Intervention, Comparator, Outcome, Study design), as summarized in Table 1.
Table 1
| Criteria | Inclusion criteria | Exclusion criteria |
|---|---|---|
| Population | Studies were included if they involved populations mean aged 60âŻyears or older, with a diagnosis of MCI. | Studies with populations whose main pathology is other than MCI (i.e., chronic diseases, physical deterioration or social problems) and/or mean aged under 60âŻyears. |
| Intervention | Studies involving NIBS combined with cognitive training in older people with MCI for 4âŻweeks or more. | Studies that include other types of complementary interventions, not related to NIBS. |
| Comparison | Interventions with active or inactive control groups. | Lack of baseline and/or follow-up data. Absence of control group. |
| Outcomes | At least one assessment of cognitive function. | Lack of baseline data and/or follow-ups. |
| Study design | Randomized controlled trials, with pre- and post-assessment. | Controlled, retrospective, prospective and cross-sectional, non-randomized studies. |
| Level of evidence | 1a. | 1b, 2a, 2b, 3a, 3b, 4 and 5. |
Selection criteria used in the systematic review with meta-analysis.
MCI: mild cognitive impairment; NIBS: noninvasive brain stimulation.
2.3 Information and database search process
Seven databases were used: Medline/PubMed, Scopus, Cochrane, Web of Science (core collection), EBSCOhost, CINAHL, and ProQuest. Medical Subject Headings (MeSH) from the US National Library of Medicine and free-text phrases related to NIBS, cognitive function, older people, and MCI were used. The following search string was applied: (âTranscranial Magnetic Stimulationâ OR âMagnetoencephalographyâ OR âTranscranial Direct Current Stimulationâ OR âElectric Stimulation Therapyâ OR âtDCSâ OR ârTMSâ) AND (âExecutive Functionâ OR âMetacognitionâ OR âAttentionâ OR âCognitionâ OR âMemoryâ OR âProblem Solvingâ OR âDecision Makingâ OR âPlanning Techniquesâ) AND (âAgedâ OR âolder adultsâ OR âolder peopleâ OR âolder subjectâ OR âagingâ OR âageingâ OR âagedâ) AND (âCognitive Dysfunctionâ OR âNeurocognitive Disordersâ OR âCognitive Impairment Syndromeâ OR âEarly Cognitive Declineâ OR âMild Cognitive Changesâ OR âMinor Cognitive Impairmentâ).
The included articles and the inclusion/exclusion criteria were reviewed by two independent experts with the following qualifications: (i) a Ph.D. in health-related sciences and (ii) peer-reviewed publications in journals with an impact factor (Journal Citation ReportsÂź). The experts were not provided with the search strategy to minimize bias. A final database search on May 30, 2025, aimed to identify relevant errata or retractions related to the included studies.
An independent expert was consulted regarding the included articles and the application of the inclusion and exclusion criteria to ensure the identification of relevant studies. Two eligibility requirements were established for the expert: (i) holding a PhD in health sciences and (ii) having peer-reviewed publications in journals with an impact factor, according to Journal Citation ReportsÂź, on topics such as virtual reality, quality of life, and cognitive function in older peoples. The search strategy was not disclosed to the expert in order to minimize bias. After these procedures were completed, the databases were searched again on August 30, 2025, to identify any relevant retractions or errata related to the included studies.
2.4 Study selection and data collection process
The studies were exported to Mendeley Reference Manager (version 2.116.1), and the selection process was documented in the PRISMA flowchart. Two authors (P. J.-O. and A. Q.) independently conducted the searches and systematically reviewed titles, abstracts, and full texts, while duplicates were removed. No discrepancies were identified at this stage. Potentially eligible articles were then re-examined, and exclusions were justified for studies that did not meet the predefined criteria. Finally, two additional reviewers (E. V.-C. and J. H.-M.) independently audited the entire selection and data extraction process.
2.5 Methodological quality assessing
The methodological quality and level of evidence were assessed using the Oxford Centre for Evidence-Based Medicine scale (29). Only level 1a studies, defined as RCTs, were included, while studies classified as levels 1b through 5 were excluded. RCTs were downgraded if concerns were identified regarding bias, consistency, accuracy, precision, or transparency of results (29).
2.6 Data collection process
Data from the included studies were extracted into a standardized form using Microsoft ExcelÂź (version 16.81), in accordance with Cochrane guidelines (30). Two researchers (P. J.-O. and A. Q.) independently performed the extractions and compared their results to ensure accuracy, with oversight provided by a third reviewer (E. V.-C.). Extracted variables included authors, country, study design, sample size, group allocation (n), mean age, type of intervention and control condition, training volume (frequency, duration, intensity), type and intensity of NIBS, cognitive assessments, and main outcomes.
2.7 Risk of bias
The risk of bias in the included RCTs was assessed using the Risk of Bias 2 (RoB 2) tool (30). Two reviewers (P. J.-O. and A. Q.) conducted the initial assessment, which was subsequently reviewed by two additional authors (E. V.-C. and J. H.-M.). Discrepancies were resolved through discussion and consensus.
2.8 Meta-analysis measures
A meta-analysis approach was applied, with the detailed methodology registered in PROSPERO (CRD42024563219). For each comparison, the standardized mean difference (SMD) was calculated using Comprehensive Meta-Analysis software (RevMan 5.4). A p-value of <0.05 was considered statistically significant (31). A random-effects model, based on the DerSimonianâLaird method, was used to estimate and combine SMDs and mean differences across outcomes such as cognitive function, comparing experimental and control groups before and after the intervention (32). This model assumed that true intervention effects varied among studies due to factors such as intervention type or duration, thereby accounting for heterogeneity in effect sizes across populations.
Results were pooled when at least three studies reported consistent findings (33). Heterogeneity was assessed using the Cochrane Q test (34) and the I2 statistic, with thresholds of <25%, 25â50, and >50% representing low, moderate, and high inconsistency, respectively (32). Eggerâs regression analysis was conducted to detect small-study effects and potential publication bias (35).
2.9 Certainty of evidence
The certainty of evidence from the included studies was evaluated using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework (36). Evidence was categorized as high, moderate, low, or very low. All analyses initially started with a high certainty rating, given the inclusion of RCTs, but were downgraded if concerns arose regarding risk of bias, consistency, accuracy, precision, transparency of results, or publication bias. Two reviewers (P. J.-O. and A. Q.) conducted independent assessments, and disagreements were resolved through consensus with a third reviewer (E. V.-C.).
3 Results
3.1 Study selection
A total of 1,689 studies were identified through the database search, with 37 excluded as duplicates. Of the remaining 1,652 records, 1,599 were excluded after screening titles and abstracts for relevance (927 based on titles and 672 based on abstracts). A full-text review was conducted for 53 references, of which 43 were excluded for not meeting the inclusion criteria: 15 due to incomplete approaches, 11 for unrelated topics, and 17 for not matching the required study design. Ultimately, 10 studies were included in the systematic review and meta-analysis (21, 37â45). The search and selection process is illustrated in a PRISMA flowchart (Figure 1) (46).
Figure 1

Flowchart of the systematic review.
3.2 Methodological quality
The methodological quality of the included studies was rated as high. All 10 studies were randomized controlled trials (RCTs) (21, 37â45), representing the highest level of evidence (level 1a) according to the Oxford Scale. This study design minimized the risk of bias and provided a robust basis for evaluating the effectiveness of interventions involving NIBS combined with cognitive training in older peoples with MCI.
3.3 Risk of bias
Three studies were assessed as having a low risk of bias across all domains (39, 41, 45). Seven studies showed some concerns in one or more domains (21, 37, 38, 40, 42â44). None of the studies were classified as having a high risk of bias. Overall, the risk of bias was considered moderate, with most studies presenting some concerns and only a few demonstrating low risk across all domains. The risk of bias assessment is presented in Figures 2, 3.
Figure 2

Risk of bias tool: traffic light chart.
Figure 3

Risk of bias tool: summary table by domain.
3.4 Characteristics of the studies
The ten studies included in this review demonstrated considerable heterogeneity in interventions, participant characteristics, and cognitive outcomes. Interventions ranged from transcranial direct current stimulation (tDCS) combined with cognitive or physical training, to repetitive transcranial magnetic stimulation (rTMS) alone, and cognitive training without neurostimulation. Overall, tDCS particularly when paired with working memory, visuo-spatial tasks, or Tai Chi consistently enhanced memory, attention, and global cognitive scores, while rTMS improved verbal fluency and daily memory performance. Some studies reported task- or domain-specific effects, and minor improvements were occasionally observed in sham or control groups. Categorizing studies by intervention type and cognitive domain suggests that combining NIBS with cognitive training may provide clinically meaningful benefits for individuals with MCI, as summarized in Table 2.
Table 2
| Author | Country | Sample (n) | Groups (n) | Mean age (y) | Training Volume | Type and Intensity of NIBS | Cognitive function | Main outcomes | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Week | Frequency (sessions/weeks) | Session duration (min) | ||||||||
| Langa and Levine (12) | CN | 201 | tDCS-WMT group (69); Sham tDCS-WMT group (64); tDCS-CCT Group (68) | 73.4 | 4 | 5 | 45 | tDCS 2âŻmA | MMSE, TMT-A, TMT-B, N back, Logical memory test | tDCS-WMT: â Memory capacity (p <âŻ0.001), fluency (p <âŻ0.001), â Delayed recall (p =âŻ0.042) and N-back task performance (p =âŻ0.04). Sham: Small â memory capacity (p =âŻ0.038) and N-back task performance (p =âŻ0.024). tDCS-CCT: â Cognitive function (p <âŻ0.001), memory capacity (p <âŻ0.001). tDCS-WMTâŻ>âŻSham (Memory); tDCS-WMTâŻ>âŻtDCS-CCT (Cognition) |
| Senczyszyn et al. (25) | BR | 34 | rTMS (17); Sham (17) | 65 | 2 | 5 | 20 | rTMS, 10âŻHz, 2000 pulses per day | RBMT, TMT-B | rTMS: â Everyday memory (p =âŻ0.029), sequencing (p =âŻ0.029), verbal fluency (p =âŻ0.036). Sham: No significant change (p >âŻ0.05). |
| Pagali et al. (26) | CN | 48 | atDCS+Visuospatial (16); Sham (32) | 70 | 4 | 3 | 30 | tDCS 1âŻmA | MMSE, TMT-A, TMT-B, Boston Naming Test, Digit Span | No significant difference in training success (p =âŻ0.74). atDCS: â positive affect (day 3). No long-term memory change (details not specified) |
| Higgins et al. (27) | DE | 39 | atDCS (16); Sham (23) | 70 | 4 | 3 | 45 | tDCS 1âŻmA | N-back, AVLT, WMT2 | No significant differences overall. atDCS: Small â N-back (p =âŻ0.06). Slightly higher performance at 7-month follow-up. |
| Page et al. (28) | IT | 27 | rTMS (11); Sham (16) | 67.85 | 4 | 5 | 20 | rTMS, 10âŻHz, 2000 pulses | RBANS | rTMS: â semantic fluency (p <âŻ0.05), story memory (p <âŻ0.05) & recall (p <âŻ0.05). No baseline differences. â MCIâŻ+âŻTMS showed more pronounced apathetic symptoms compared to healthy controls |
| Manterola and Zavando (29) | TH | 45 | tDCS (23); Sham (22) | 68.39 | 4 | 3 | 20 | tDCS 2âŻmA |
TMSE, MoCA, Singing task | No group differences in TMSE/MoCA. tDCS: â RVP hits (pâŻ<âŻ0.001), â SWM errors, â DMS hits (p <âŻ0.001). |
| Higgins et al. (30) | IRN | 60 | tDCS-DLPFC (20); tDCS-DALT (20); Sham (20) | 68.88 | 2 | 5 | 20 | tDCS 2âŻmA |
MoCA, QoLAD | tDCS-DLPFC & tDCS-DALT: â MoCA at 2âŻweeks later (p â€âŻ0.05), 1âŻmonth later (p â€âŻ0.05), 3âŻmonths later (p â€âŻ0.05). Sham: no change (p >âŻ0.05). tDCS-DLPFC & tDCS-DALT: â QoLAD at 3âŻmonths later (p =âŻ0.001). |
| Verhagen et al. (31) | TW | 21 | tDCS+ICCT: (11); Sham+ICCT (10) | 70 | 5 | 3 | 20 | tDCS 2âŻmA |
MoCA, TMT-A, TMT-B, N back, CVVLT | Both groups: â Cognition (p <âŻ0.001). tDCS+ICCT: Stronger effects on MoCA, TMT, CVVLT, N-back (p â€âŻ0.05). Sham: Modest gains. No change in CDR. |
| Higgins et al. (32) | HK | 67 | tDCS+CT (22); Sham+CT (24); CT only (21) | 69.8 | 3 | 3 | 30âŻmin | tDCS 1.5âŻmA |
MoCA, TMT-A, TMT-B, DST, RBMT-3 | tDCS+CT: â working memory (pâŻâ€âŻ0.05), attention (time & reaction) (p â€âŻ0.05). Sham: No decline reported. |
| VĂĄsquez-Carrasco et al. (3) | CN | 180 | TCT (44); TCS (49); WAT (44); WAS (43) | 60.25 | 12 | 3 | 60 | tDCS 2âŻmA |
MoCA, AVLT, Stroop Test | TCT, WAT or WAS: â MoCA (p <âŻ0.001), AVLT recall (p =âŻ0.015), â Stroop time after 12âŻweeks (p =âŻ0.004). |
Selected studies on non-invasive brain stimulation combined with cognitive training in older people with mild cognitive impairment.
atDCS: anodal transcranial direct current stimulation; AVLT: Auditory Verbal Learning Test; BR: Brazil; CCT: Cognitive Control Training; CDR: Clinical Dementia Rating; CN: China; CT: Cognitive training; CVVLT: Chinese Version of the Verbal Learning Test; DALT: Dorsolateral Anterior Left Temporal; DLPFC: Dorsolateral Prefrontal Cortex; DMS: Delayed Matching to Sample; DST: Digit Span Test; DE: Germany; HK: Hong Kong; ICCT: Integrated Cognitive and Cognitive Training; IRN: Iran; IT: Italy; MCI: Mild Cognitive Impairment; MMSE: Mini-Mental State Examination; MoCA: Montreal Cognitive Assessment; N back: Working Memory Test; NIBS: Non-Invasive Brain Stimulation; QoLAD: Quality of Life in Alzheimerâs Disease; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status; RBMT: Rivermead Behavioral Memory Test; RBMT-3: Rivermead Behavioral Memory Test 3; rTMS: Repetitive Transcranial Magnetic Stimulation; RVP: Rapid Visual information Processing; SWM: Spatial Working Memory; TH: Thailand; TCT: Tai Chi Combined with tDCS; TCS: Tai Chi Combined with Sham tDCS; tDCS: transcranial direct current stimulation; TMT-A: Trail Making Test Part A; TMT-B: Trail Making Test Part B; TMSE: Thai Mental State Examination; tDCS: Transcranial Direct Current Stimulation; TW: Taiwan; WAS: Walking Combined with Sham tDCS; WAT: Walking Combined with tDCS; WMT: Working Memory Training.
3.5 Sample characteristics
The total population included in this systematic review and meta-analysis comprised 722 older peoples, of whom 71.4% were female, with a mean age of 69.5âŻyears. Sample sizes ranged from 22 participants (43) to 201 participants (15), reflecting variability in study design and intervention scope. The interventions assessed included tDCS combined with cognitive training, repetitive rTMS, and cognitive training alone, each evaluated for their effects on cognitive function in older peoples with MCI.
3.6 Doses and interventions performed
The included studies implemented a range of NIBS and cognitive interventions aimed at improving cognitive function in individuals with MCI. Cognitive training programs, such as memory and attention tasks combined with neurostimulation techniques like tDCS and rTMS, primarily targeted cognitive performance (21, 37, 43). Individualized interventions combining physical activity and cognitive training, such as Tai Chi or walking paired with tDCS, also demonstrated significant improvements in cognitive outcomes (44, 45). Intervention protocols varied in duration and frequency, ranging from 4âŻweeks with three to five sessions of 20â45âŻmin per week (21, 37, 43) to 12âŻweeks with multiple 30â60-min sessions (45). Most programs were conducted at moderate intensity, with tDCS doses between 1 and 2âŻmA (21, 43).
3.7 Cognitive function
The overall effects of NIBS on cognitive function variables are summarized in Table 3, with corresponding forest plots presented in Supplementary Figures 1â3. Significant moderate effects (pâŻ<âŻ0.05) were observed for Trail-Making Test Part A (TMT-A; ESâŻ=âŻ0.54) and MoCA (pâŻ>âŻ0.05), indicating that NIBS preferentially enhances processing speed, attention, and global cognitive performance. In contrast, TMT-B showed no significant differences, with small to moderate effect sizes (ESâŻ=âŻ0.05â0.52). These differential outcomes may reflect the varying sensitivity of cognitive measures to NIBS: TMT-A and MoCA primarily assess domains such as sustained attention, executive control, and working memory, which are more directly influenced by cortical excitability and network plasticity modulated by NIBS. Conversely, TMT-B, which imposes greater demands on cognitive flexibility and task-switching, may require more extensive or targeted interventions to elicit measurable improvements. Considering these distinctions enhances the interpretative rigor and underscores the importance of selecting appropriate outcome measures aligned with the neurophysiological mechanisms targeted by NIBS.
Table 3
| Tests | n of studies | n of experimental groups | n of control groups | Total participants | ES (95%CI) | p | I 2 (%) | Eggerâs test (p) | RW (%) |
|---|---|---|---|---|---|---|---|---|---|
| MoCA | 5 | 5 | 5 | 277 | 0.52 (0.34 to 1.17) | 0.05 | 76.6 | 0.00 | 7.21â8.53 |
| TMT-A | 4 | 4 | 4 | 294 | 0.54 (0.003 to 1.08) | 0.04 | 76.6 | 0.00 | 21.8â25.2 |
| TMT-B | 5 | 5 | 5 | 328 | 0.05 (â0.35 to 0.45) | 0.80 | 65.6 | 0.02 | â0.93-11.6 |
Effects of NIBS combined with cognitive training on cognitive function in older people with mild cognitive impairment.
CI: confidence interval; ES: effect size; MoCA: Montreal Cognitive Assessment; RW: relative weight; TMT-A: Trail Making Test Part A; TMT-B: Trail Making Test Part B.
3.8 Certainty of evidence
The available evidence is not robust enough to provide definitive recommendations for interventions targeting cognitive function in older people with MCI. While certain studies have shown promising results, the overall findings highlight the necessity for further research to draw clearer conclusions and develop evidence-based strategies for this population (Table 4).
Table 4
| Certainty of evidence | N of patients | Effect | Certainty | Importance | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N of studies | Study design | Risk assessment | Inconsistency | Indirect evidence | Vagueness | Other considerations | NIBS and cognitive training | Active control group | Relative (95% CI) | Absolute (95% CI) | ||
| MoCA (Montreal Cognitive Assessment) | ||||||||||||
| 5 | RCT | Serious | Itâs not serious | Itâs not serious | Itâs not serious | None | 120/237 (50.6%) | 117/237 (49.4%) |
Not estimable | +++ Moderate |
IMPORTANT | |
| TMT (Trail Making Test) A | ||||||||||||
| 3 | RCT | Serious | Itâs not serious | Itâs not serious | Itâs not serious | None | 86/175 (49.1%) | 89/175 (50.9%) | Not estimable | +++ Moderate |
IMPORTANT | |
| TMT (Trail Making Test) B | ||||||||||||
| 4 | RCT | Serious | Itâs not serious | Itâs not serious | Itâs not serious | None | 101/209 (48.3%) | 108/209 (51.7%) | Not estimable | +++ Moderate |
IMPORTANT | |
Assessment of methodological quality using the GRADEpro tool.
CI: confidence interval; NIBS: noninvasive brain stimulation; RCT: randomized clinical Trial.
3.9 Adverse effects and adherence
The studies analyzed in this systematic review with meta-analysis indicated good participant adherence (87.7%) and did not mention any adverse effects. This implies that the interventions were generally well tolerated and practical for older people with MCI, highlighting their potential for wider application in similar populations.
4 Discussion
4.1 Cognitive functions MoCA
The meta-analysis revealed significant moderate effects (pâŻ<âŻ0.05) supporting the effectiveness of both NIBS and cognitive training, as evaluated by the MoCA. No significant differences were observed in baseline MoCA scores between active and sham groups in a randomized controlled trial investigating the effects of tDCS combined with working memory training in older peoples with MCI (pâŻ>âŻ0.05) (47). Draaisma et al. (48) reported that in a cohort of 20 healthy older peoples, personalized theta transcranial alternating current stimulation (tACS) significantly improved performance in a motor sequence learning task with a high working memory load (pâŻ<âŻ0.001), as well as task speed (pâŻ<âŻ0.001) and accuracy (pâŻ=âŻ0.03). Similarly, a study involving 229 healthy participants demonstrated substantial improvements in inhibition and cognitive flexibility after both tACS and tDCS, with no significant differences between the two methods. Functional near-infrared spectroscopy showed that tDCS reduced functional connectivity in relevant cortical regions, suggesting that transcranial stimulation enhances executive function, with tDCS conferring superior neural benefits compared to tACS (49). Additionally, another study reported cognitive improvements following 12 sessions of either active or sham tDCS in older peoples, with the tDCS plus sertraline group exhibiting a significant increase in MoCA scores (pâŻ=âŻ0.01) (50). NIBS targets cortical excitability, modulating neuronal activity and promoting the formation of new synaptic connections, repeated and spaced-out application of stimuli has been shown to be more effective in inducing lasting changes in synaptic plasticity, a principle that aligns with the mechanisms of learning and memory in the human brain (51). Furthermore, NIBS has shown potential in the treatment of neurocognitive disorders by improving neuronal connectivity and restoring altered cognitive functions (52).
4.2 Cognitive functions TMT
The meta-analysis revealed significant moderate effects (pâŻ<âŻ0.05) in favor of NIBS combined with cognitive training for TMT-A (pâŻ=âŻ0.04). In contrast, no significant differences were found for TMT-B. One RCT reported that the combination of tDCS and Nintendo Switch significantly improved performance on both TMT-A (pâŻ=âŻ0.03) and TMT-B (pâŻ=âŻ0.04) in individuals with chronic stroke, suggesting that interactive training may enhance the effects of brain stimulation (53). Similar findings were reported in an RCT with 103 participants diagnosed with depression who received tDCS, where a significant improvement in TMT-A performance was observed (pâŻâ€âŻ0.02), indicating enhanced processing speed (49). However, a placebo-controlled RCT involving 25 patients with Alzheimerâs disease, in which tDCS was applied to the left temporal cortex over six sessions, reported no significant effects on either TMT-A (pâŻ=âŻ0.378) or TMT-B (pâŻ=âŻ0.093) (54). Overall, the findings suggested that NIBS combined with cognitive training improved certain cognitive abilities, particularly processing speed and general cognitive performance, as reflected in TMT-A and MoCA scores. However, its effects on more complex executive tasks, such as those measured by TMT-B, remained less clear. Research using tDCS and tACS has shown promising benefits for executive function and working memory, and plasticity though results vary depending on the specific task and the population studied (55).
4.3 Limitations and strengths
Limitations include: (i) The relatively small number of included studies reduces statistical power and robustness of conclusions; (ii) Substantial heterogeneity in intervention protocols complicates direct comparisons; (iii) Evidence certainty was rated as low to moderate, with methodological concerns in most trials and short follow-up periods (â€3âŻmonths); (iv) Generalizability is limited by geographical concentration and sample imbalances; (v) High equipment costs may hinder accessibility in community settings; (vi) specialized training requirements could restrict implementation, and (vii) biological variability (e.g., cranial anatomy) may influence stimulation efficacy.
Strengths include: (i) Exclusive inclusion of RCTs enhanced methodological rigor and reliability of findings; (ii) Multiple neurostimulation modalities, including tDCS and rTMS, were evaluated in combination with cognitive training, providing a comprehensive assessment; (iii) Significant cognitive benefits were identified in domains such as working memory, processing speed, and verbal fluency, suggesting promise for improving cognitive function in older peoples with MCI; and (iv) The review offers practical insights for future research and potential population-level implementation strategies.
4.4 Practical applications
The moderate effect sizes observed for cognitive outcomes such as TMT-A and MoCA highlight the innovative potential of combining NIBS with targeted cognitive exercises for older peoples with MCI. This approach represents a scalable and practical strategy for enhancing cognitive function within community or outpatient settings. Specifically, pairing low intensity tDCS (1â2âŻmA) with working memory or verbal fluency training can be delivered safely in small groups, with high adherence (87.7%) and no reported adverse events. The clinical significance lies in its feasibility: interventions can be administered by allied health professionals with minimal equipment, guided by standardized manuals detailing electrode placement, session timing (20â45âŻmin, 3â5 sessions/week), and progression criteria. Furthermore, digital platforms offer opportunities for remote supervision, real-time data collection, and participant engagement, supporting broader implementation and integration into routine care. Overall, this combined approach provides a replicable, low-risk, and evidence-based pathway for translating cognitive enhancement research into practical clinical applications.
4.5 Clinical applications
Clinicians in geriatric services, or neurorehabilitation settings may consider incorporating NIBS combined with cognitive training as an adjunct to conventional pharmacological and behavioral therapies. Evidence from RCTs demonstrating improvements in processing speed and memory capacity (31, 33) highlights the potential of these interventions for individuals with early MCI. Clear patient selection criteria including baseline MoCA scores, comorbidities, and cranial anatomy are critical to optimize efficacy and reduce variability. Standardized assessments at baseline, mid-intervention, and follow-up can guide personalized adjustments. Successful integration of NIBS protocols will require interdisciplinary collaboration among neurologists, psychiatrists, neuropsychologists, and rehabilitation specialists to monitor safety, ensure adherence, and evaluate long-term functional outcomes such as daily living activities and quality of life.
4.6 Epidemiological applications
At a population level, NIBS-based cognitive training has the potential to slow MCI progression and reduce dementia incidence among older peoples. Epidemiological modeling incorporating effect size estimates can quantify potential reductions in disability-adjusted life years (DALYs) and healthcare costs. However, the high cost of equipment may pose barriers in community-based settings, requiring reimbursement strategies and scalable implementation frameworks to ensure accessibility across socioeconomic groups. In addition, specialized training and technical expertise are essential for safe and effective administration, which may limit availability in under-resourced health systems. Biological variability, particularly differences in cranial anatomy, can further influence stimulation efficacy, highlighting the need for individualized approaches and adaptive protocols. Large-scale, population-level studies are warranted to assess the durability of cognitive benefits and safety in real-world settings. Integration into national aging policies through community health programs, clinician training, and equitable funding models could strengthen preventive efforts, inform evidence-based guidelines for MCI management, and support sustainable cognitive health interventions at the societal level.
5 Conclusion
The combination of NIBS and cognitive training interventions demonstrated significant improvements in cognitive functions in older people with MCI, particularly in tasks like TMT-A and MoCA where moderate effects were observed. However, no significant differences were found in TMT-B scores, indicating that while the interventions may benefit some cognitive processes, their impact on others remains uncertain.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary material, further inquiries can be directed to the corresponding authors.
Author contributions
EV-C: Writing â original draft, Writing â review & editing, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation. PJ-O: Writing â original draft, Writing â review & editing, Data curation, Investigation, Software. AQ: Writing â original draft, Writing â review & editing, Data curation, Investigation, Software. JH-M: Writing â original draft, Writing â review & editing, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Validation. BB: Writing â original draft, Writing â review & editing, Formal analysis, Validation. EC-P: Writing â original draft, Writing â review & editing, Formal analysis. PS: Writing â original draft, Writing â review & editing, Investigation. CS: Writing â original draft, Writing â review & editing, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision. PV-B: Writing â original draft, Writing â review & editing, Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Software, Supervision, Validation.
Funding
The author(s) declare that financial support was received for the research and/or publication of this article. The APC charges were covered by Universidad de La Frontera.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The authors declare that no Gen AI was used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisherâs note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2025.1659208/full#supplementary-material
References
1.
World Health Organization . Ageing and health facts and figures. (2021). Available online at: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health (Accessed September 24, 2025).
2.
Petersen RC Caracciolo B Brayne C Gauthier S Jelic V Fratiglioni L . Mild cognitive impairment: a concept in evolution. J Intern Med. (2014) 275:214â28. doi: 10.1111/joim.12190
3.
Våsquez-Carrasco E Rojas M Larenas L Ferrada A Hernandez-Martinez J Ahumada-Méndez F et al . Effectiveness of non-pharmacological interventions for sleep disorders in enhancing quality of life, cognitive function, and sleep quality in older adults with mild cognitive impairment: a systematic review and meta-analysis. Medicina (Kaunas). (2025) 61:583. doi: 10.3390/medicina61040583
4.
Sanford AM . Mild cognitive impairment. Clin Geriatr Med. (2017) 33:325â37. doi: 10.1016/j.cger.2017.02.005
5.
Bai W Chen P Cai H Zhang Q Su Z Cheung T et al . Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta-analysis and systematic review of epidemiology studies. Age Ageing. (2022) 51:afac173. doi: 10.1093/ageing/afac173
6.
United Nations, Department of Economic and Social Affairs World population prospects 2022: summary of results (2022) Available online at: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf
7.
Prince MJ Wu F Guao Y GutiĂ©rrez L O'Donnell M Sullivan R et al . The burden of disease in older people and implications for health policy and practice. Lancet. (2015) 385:548â56. doi: 10.1016/S0140-6736(14)61347-7
8.
Soysal P Stubbs B Lucato P Luchini C Solmi M Peluso R et al . Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. (2016) 31:1â8. doi: 10.1016/j.arr.2016.08.006
9.
Navarrete-Villanueva D GĂłmez-Cabello A MarĂn-Puyalto J Moreno LA Vicente-RodrĂguez G CasajĂșs JA . Frailty and physical fitness in elderly people: a systematic review and meta-analysis. Sports Med. (2021) 51:143â60. doi: 10.1007/s40279-020-01361-1
10.
BontĂ© F Girard D Archambault JC DesmouliĂšre A . Skin changes during ageing. Subcell Biochem. (2019) 91:249â80. doi: 10.1007/978-981-13-3681-2_10
11.
Fonte Sevillano T Santos Hedman DJ . Mild cognitive decline in the elderly older than 85 years. Rev Cubana Med. (2020) 59:1
12.
Langa KM Levine DA . The diagnosis and management of mild cognitive impairment: a clinical review. JAMA. (2014) 312:2551â61. doi: 10.1001/jama.2014.13806
13.
VĂĄsquez-Carrasco E Hernandez-Martinez J SepĂșlveda-RamĂrez M Carmine F Sandoval C Nobari H et al . Effectiveness of virtual reality interventions on quality of life, cognitive function and physical function in older people with Alzheimerâs disease: a systematic review. Ageing Res Rev. (2025) 109:102785. doi: 10.1016/j.arr.2025.102785
14.
GutiĂ©rrez RodrĂguez J GuzmĂĄn GutiĂ©rrez G . Definition and prevalence of mild cognitive impairment. Rev Esp Geriatr Gerontol. (2017) 52:3â6. doi: 10.1016/S0211-139X(18)30072-6
15.
Ayala San MartĂn LS . Promotion and prevention of cognitive decline and dementia in the elderly. Enferm Neurol. (2020) 14:e14304.
16.
VĂĄsquez-Carrasco E Jamett-Oliva P Hernandez-Martinez J Riquelme-HernĂĄndez C VillagrĂĄn-Silva F Branco BHM et al . Effectiveness of occupational therapy interventions on activities of daily living, cognitive function, and physical function in middle-aged and older people with chronic stroke: a systematic review with meta-analysis. J Clin Med. (2025) 14:2197. doi: 10.3390/jcm14072197
17.
Våsquez-Carrasco E Gómez CS Valdés-Badilla P Hernandez-Martinez J Villagrån-Silva F Aravena-Sagardia P et al . Effectiveness of combined cognitive stimulation and physical activity interventions on activities of daily living, cognitive function, and physical function in older people with mild cognitive impairment: a systematic review with meta-analysis. J Clin Med. (2025) 14:2261. doi: 10.3390/jcm14072261
18.
Ali N Tian H Thabane L Ma J Wu H Zhong Q et al . The effects of dual-task training on cognitive and physical functions in older adults with cognitive impairment: a systematic review and meta-analysis. J Prev Alzheimers Dis. (2022) 9:359â70. doi: 10.14283/jpad.2022.16
19.
Fomenko A Chen KS Nankoo JF Saravanamuttu J Wang Y El-Baba M et al . Systematic examination of low-intensity ultrasound parameters on human motor cortex excitability and behavior. eLife. (2020) 9:e54497. doi: 10.7554/eLife.54497
20.
Thair H Holloway AL Newport R Smith AD . Transcranial direct current stimulation (tDCS): a beginner's guide for design and implementation. Front Neurosci. (2017) 11:641. doi: 10.3389/fnins.2017.00641
21.
Lu H Chan SSM Chan WC Lin C Cheng CPW Chiu WL . Randomized controlled trial of tDCS on cognition in 201 seniors with mild neurocognitive disorder. Ann Clin Transl Neurol. (2019) 6:1938â48. doi: 10.1002/acn3.50823
22.
Castellote-Caballero Y CarcelĂ©n Fraile MDC Aibar-AlmazĂĄn A Afanador-Restrepo DF GonzĂĄlez-MartĂn AM . Effect of combined physical-cognitive training on the functional and cognitive capacity of older people with mild cognitive impairment: a randomized controlled trial. BMC Med. (2024) 22:281. doi: 10.1186/s12916-024-03469-x
23.
Sandrini M Manenti R Gobbi E Rusich D Bartl G Cotelli M . Transcranial direct current stimulation applied after encoding facilitates episodic memory consolidation in older adults. Neurobiol Learn Mem. (2019) 163:107037. doi: 10.1016/j.nlm.2019.107037
24.
Yang T Liu W He J Gui C Meng L Xu L et al . The cognitive effect of non-invasive brain stimulation combined with cognitive training in Alzheimerâs disease and mild cognitive impairment: a systematic review and meta-analysis. Alzheimer's Res Ther. (2024) 16:140. doi: 10.1186/s13195-024-01505-9
25.
Senczyszyn A SzczeĆniak D Wieczorek T Maciaszek J MaĆecka M BogudziĆska B et al . Improvement of working memory in older adults with mild cognitive impairment after repetitive transcranial magnetic stimulation â a randomized controlled pilot study. Front Psych. (2023) 14:1196478. doi: 10.3389/fpsyt.2023.1196478
26.
Pagali SR Kumar R LeMahieu AM Basso MR Boeve BF Croarkin PE et al . Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment, Alzheimerâs disease, Alzheimerâs disease-related dementias, and other cognitive disorders: a systematic review and meta-analysis. Int Psychogeriatr. (2024) 36:880â928. doi: 10.1017/S1041610224000085
27.
Higgins JPT Thomas J Chandler J Cumpston M Li T Page M et al . Chapter 8: assessing risk of bias in a randomized trial In: HigginsJPTThomasJChandlerJet al, editors. Cochrane handbook for systematic reviews of interventions: . Chichester, UK: John Wiley & Sons, Ltd. (2023).
28.
Page MJ McKenzie JE Bossuyt PM Boutron I Hoffmann TC Mulrow CD et al . PRISMA 2020 statement: an updated guideline for the publication of systematic reviews. BMJ. (2021) 74:790â9. doi: 10.1136/bmj.n71
29.
Manterola C Zavando D . How to interpret the âlevels of evidenceâ in different clinical scenarios. Rev Chil Cir. (2009) 61:582â95. doi: 10.4067/S0718-40262009000600017
30.
Higgins JPT LĂłpez-LĂłpez JA Becker BJ Davies SR Dawson S Grimshaw JM et al . Synthesizing quantitative evidence in systematic reviews of complex health interventions. BMJ Glob Health. (2019) 4:e000858. doi: 10.1136/bmjgh-2018-000858
31.
Verhagen AP de Vet HC de Bie RA Kessels AG Boers M Bouter LM et al ., The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensusJ Clin Epidemiol (1998) 511235â1241 doi: 10.1016/s0895-4356(98)00131-0
32.
Higgins JPT Green S . Cochrane handbook for systematic reviews of interventions In. The Cochrane Collaboration. 5th ed: Higgins JPT, Green S, ed. Chichester, UK: John Wiley & Sons, Ltd. (2008).
33.
Davey J Turner RM Clarke MJ Higgins JPT . Characteristics of meta-analyses and their component studies in the Cochrane database of systematic reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol. (2011) 11:160. doi: 10.1186/1471-2288-11-160
34.
Morris SB DeShon RP . Combining effect size estimates in meta-analysis with repeated measures and independent-groups designs. Psychol Methods. (2002) 7:105â25. doi: 10.1037/1082-989x.7.1.105
35.
Higgins JPT Thompson SG . Quantifying heterogeneity in a meta-analysis. Stat Med. (2002) 21:1539â58. doi: 10.1002/sim.1186
36.
Xie CX Machado GC . Clinimetrics: grading of recommendations, assessment, development and evaluation (GRADE). J Physiother. (2021) 67:66. doi: 10.1016/j.jphys.2020.07.003
37.
Drumond Marra HL Myczkowski ML Maia MemĂłria C Arnaut D Leite Ribeiro P Sardinha Mansur CG et al . Transcranial magnetic stimulation to address mild cognitive impairment in the elderly: a randomized controlled study. Behav Neurol. (2015) 2015:287843. doi: 10.1155/2015/287843
38.
de Sousa AVC Grittner U Rujescu D KĂŒlzow N Flöel A . Impact of 3-day combined anodal transcranial direct current stimulation-visuospatial training on object-location memory in healthy older adults and patients with mild cognitive impairment. J Alzheimer's Dis. (2020) 75:223â44. doi: 10.3233/JAD-191234
39.
Antonenko D Fromm AE Thams F Kuzmina A Backhaus M Knochenhauer E et al . Cognitive training and brain stimulation in patients with cognitive impairment: a randomized controlled trial. Alzheimer's Res Ther. (2024) 16:6. doi: 10.1186/s13195-024-01381-3
40.
Esposito S Trojsi F Cirillo G de Stefano M di Nardo F Siciliano M et al . Repetitive transcranial magnetic stimulation (rTMS) of dorsolateral prefrontal cortex may influence semantic fluency and functional connectivity in fronto-parietal network in mild cognitive impairment (MCI). Biomedicine. (2022) 10:994. doi: 10.3390/biomedicines10050994
41.
Stonsaovapak C Hemrungroj S Terachinda P Piravej K . Effect of anodal transcranial direct current stimulation at the right dorsolateral prefrontal cortex on cognitive function in patients with mild cognitive impairment: a randomized double-blind controlled trial. Arch Phys Med Rehabil. (2020) 101:1279â87. doi: 10.1016/j.apmr.2020.03.023
42.
Rezakhani S Amiri M Hassani A Esmaeilpour K Sheibani V . Anodal HD-tDCS on the dominant anterior temporal lobe and dorsolateral prefrontal cortex: clinical results in patients with mild cognitive impairment. Alzheimer's Res Ther. (2024) 16:27. doi: 10.1186/s13195-023-01370-y
43.
Lau CI Liu MN Cheng FY Wang HC Walsh V Liao YY . Can transcranial direct current stimulation combined with interactive computerized cognitive training boost cognition and gait performance in older adults with mild cognitive impairment? A randomized controlled trial. J Neuroeng Rehabil. (2024) 21:26. doi: 10.1186/s12984-024-01313-0
44.
Gonzalez PC Fong KNK Brown T . Transcranial direct current stimulation as an adjunct to cognitive training for older adults with mild cognitive impairment: a randomized controlled trial. Ann Phys Rehabil Med. (2021) 64:101536. doi: 10.1016/j.rehab.2021.101536
45.
Xu Y Zhu J Liu H Qiu Z Wu M Liu J et al . Effects of tai chi combined with tDCS on cognitive function in patients with MCI: a randomized controlled trial. Front Public Health. (2023) 11:1199246. doi: 10.3389/fpubh.2023.1199246
46.
Haddaway NR Page MJ Pritchard CC McGuinness LA . PRISMA2020: an R package and shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimized digital transparency and open synthesis. Campbell Syst Rev. (2022) 18:e1230. doi: 10.1002/cl2.1230
47.
Assecondi S Hu R Kroeker J Eskes G Shapiro K . Older adults with lower working memory capacity benefit from transcranial direct current stimulation when combined with working memory training: a preliminary study. Front Aging Neurosci. (2022) 14:1009262. doi: 10.3389/fnagi.2022.1009262
48.
Draaisma LR Wessel MJ Moyne M Morishita T Hummel FC . Targeting the frontoparietal network using bifocal transcranial alternating current stimulation during a motor sequence learning task in healthy older adults. Brain Stimul. (2022) 15:968â79. doi: 10.1016/j.brs.2022.06.012
49.
Lu H Zhang Y Qiu H Zhang Z Tan X Huang P et al . A new perspective for evaluating the efficacy of tACS and tDCS in improving executive functions: a combined tES and fNIRS study. Hum Brain Mapp. (2024) 45:e26559. doi: 10.1002/hbm.26559
50.
Brunoni AR Tortella G Benseñor IM Lotufo PA Carvalho AF Fregni F . Cognitive effects of transcranial direct current stimulation in depression: results from the SELECT-TDCS trial and insights for further clinical trials. J Affect Disord. (2016) 202:46â52. doi: 10.1016/j.jad.2016.03.066
51.
Goldsworthy MR Pitcher JB Ridding MC . Spaced noninvasive brain stimulation: prospects for inducing long-lasting human cortical plasticity. Neurorehabil Neural Repair. (2015) 29:714â21. doi: 10.1177/1545968314562649
52.
Xiao H Meng Y Liu S Cao Y Sun H Deng G et al . Non-invasive brain stimulation for treating catatonia: a systematic review. Front Psych. (2023) 14:1135583. doi: 10.3389/fpsyt.2023.1135583
53.
Kim J Lee M Yim J . A new approach to transcranial direct current stimulation in improving cognitive motor learning and hand function with the Nintendo switch in stroke survivors. Med Sci Monit. (2019) 25:9555â62. doi: 10.12659/MSM.921081
54.
Bystad M GrĂžnli O Rasmussen ID Gundersen N Nordvang L Wang-Iversen H et al . Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer's disease: a randomized, placebo-controlled trial. Alzheimer's Res Ther. (2016) 8:13. doi: 10.1186/s13195-016-0180-3
55.
Bonanno M Maggio MG Quartarone A Morone G De Nunzio AM Militi D et al . Enhancing functional motor outcomes in chronic stroke: a systematic review of the growing role of non-invasive brain stimulation. PLoS One. (2025) 20:e0327583. doi: 10.1371/journal.pone.0327583
Summary
Keywords
aged, cognition, older people, rehabilitation, technology
Citation
VĂĄsquez-Carrasco E, Jamett-Oliva P, Quijada A, Hernandez-Martinez J, Branco BHM, Carmine-Peña E, SepĂșlveda P, Sandoval C and ValdĂ©s-Badilla P (2025) Effects of non-invasive brain stimulation combined with cognitive training on cognitive functions in older people with mild cognitive impairment: a systematic review with meta-analysis. Front. Med. 12:1659208. doi: 10.3389/fmed.2025.1659208
Received
03 July 2025
Accepted
19 September 2025
Published
09 October 2025
Volume
12 - 2025
Edited by
Xiao Hou, Beijing Sport University, China
Reviewed by
Hongmei Li, South-Central University for Nationalities, China
Chen Cong Hang, Macao Polytechnic University, Macao SAR, China
Updates
Copyright
© 2025 VĂĄsquez-Carrasco, Jamett-Oliva, Quijada, Hernandez-Martinez, Branco, Carmine-Peña, SepĂșlveda, Sandoval and ValdĂ©s-Badilla.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paulina SepĂșlveda, paulina.sepulveda@ufrontera.cl; Pablo ValdĂ©s-Badilla, valdesbadilla@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.